Most Recent
Construction PRO
Corporate advisory firm Cadence has left court worse off after bringing a defects suit against a builder and subcontractor on a residential development in New South Wales’ south coast, with the builder winning a $140,000 judgment on its cross-claim.
The Parramatta Eels and National Rugby League player Zac Lomax have reached a settlement in a contract dispute over his plans to join the Melbourne Storm.
A University of NSW employee has lost her bid to work exclusively from home to care for her young child, with the Fair Work Commission saying her request for a flexible work arrangement, while “reasonable”, was invalid under the Fair Work Act.
NAB super fund trustee NULIS Nominees had no power to continue charging members for $165 million in fees to pay adviser commission after conflicted remuneration was banned in 2016, an appeals court has heard.
Two victims of collapsed investment firm Courtenay House have won a case against the real estate agent who persuaded them to invest hundreds of thousands of dollars into the $180 million Ponzi scheme.
The director of a documentary about a US narcotics officer during the 1990s 'war on drugs' has won his copyright suit against the film's producers, with a judge finding his moral rights under the Copyright Act were infringed by their failure to credit him as the director.
A Federal Circuit Court judge who has been in the spotlight for his decisions has scolded a Perth law firm and barrister facing a sexual harassment case, after they sought to vacate the trial date due to counsel availability.
A judge has approved a $13.5 million settlement in a class action against the director of collapsed sandalwood producer Quintis, but has reduced deductions sought by the plaintiff's lawyers and funder, and denied a payout to the funder of a competing case.
ASIC has filed proceedings against Auto & General, alleging tens of thousands of Budget Direct customers lost discounts they were promised and were overcharged premiums for several years.
Bayer and Teva have lost their challenge to Indian drug maker Cipla’s extension of its patent for an allergy medication, with IP Australia finding a failure to pay renewal fees on time was due to a genuine error.